The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
Open accessAbstract
BACKGROUND: The diagnostic and prognostic significance of carcinoembryonic antigen (CEA), carbohydrate associated antigen 19-9 (CA19-9), alpha-fetoprotein (AFP) and cancer antigen 125 (CA125) in early gastric cancer have not been investigated yet. Thus, the present study aimed to explore the diagnostic and prognostic significance of the four tumor markers for early gastric cancer. METHODS: From September 2008 to March 2015, 587 early gastric cancer patients were given radical gastrectomy in our center. The clinicopathological characteristics were recorded. The association between levels of CEA and CA19-9 and clinicopathological characteristics and prognosis of patients were analyzed. RESULTS: There were 444 men (75.6%) and 143 women (24.4%). The median age was 57 years (ranged 21-85). The 1-, 3- and 5-year overall survival rate was 99.1%, 96.8% and 93.1%, respectively. The positive rate of CEA, CA19-9, AFP and CA125 was 4.3%, 4.8%, 1.5% and 1.9%, respectively. The positive rate of all markers combined was 10.4%. The associations between the clinicopathological features and levels of CEA and CA19-9 were analyzed. No significant association was found between CEA level and clinicopathological features. However, elevated CA19-9 level was correlated with female gender and presence of lymph node metastasis. Age > 60 years old, presence of lymph node metastasis and elevation of CEA level were independent risk factors for poor prognosis of early gastric cancer. CONCLUSIONS: The positive rates of CEA, CA19-9, APF and CA125 were relatively low for early gastric cancer. Elevation of CA19-9 level was associated with female gender and presence of lymph node metastasis. Elevation of CEA level was an independent risk factor for the poor prognosis of early gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Japanese gastric cancer treatment guidelines 2010 (ver. 3)
Japanese Gastric Cancer Association (2011) · Gastric Cancer · doi:10.1007/s10120-011-0042-4 · Cited by 2,168
Pyo, J. H., Lee, H., Min, B.-H., Lee, J. H., Choi, M. G., Lee, J. H., Sohn, T. S., Bae, J. M., Kim, K. M., Ahn, J. H., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.427 · Cited by 195
He, C.-Z., Zhang, K.-H., Li, Q., Liu, X.-H., Hong, Y., & Lv, N.-H. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-87 · Cited by 161
Liang, Y., Wang, W., Fang, C., Raj, S. S., Hu, W.-M., Li, Q.-W., & Zhou, Z.-W. (2016) · Oncotarget · doi:10.18632/oncotarget.10391 · Cited by 125
Deng, K., Yang, L., Hu, B., Wu, H., Zhu, H., & Tang, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124151 · Cited by 106
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients
Yamamoto, M., Baba, H., Toh, Y., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0189-2 · Cited by 52
Early Gastric Cancer: Current Advances of Endoscopic Diagnosis and Treatment
Zhu, L.-L., Qin, J.-Y., Wang, J., Guo, T.-J., Wang, Z., & Yang, J.-L. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/9638041 · Cited by 43
Multi-biomarker pattern for tumor identification and prognosis
Rodríguez‐Enríquez, S., Pacheco-Velázquez, S. C., Gallardo‐Pérez, J. C., Marín‐Hernández, Á., Aguilar-Ponce, J. L., Ruíz‐García, E., RuizGodoy-Rivera, L. M., Meneses-García, A., & Moreno‐Sánchez, R. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23224 · Cited by 32
Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer
Xiao, J., He, X., Wang, Z., Hu, J., Sun, F., Qi, F., Yang, S., & Xiao, Z. (2013) · Tumor Biology · doi:10.1007/s13277-013-1177-1 · Cited by 29
Cited by
Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., & Sitarz, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114012 · Cited by 1,520
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Recent advances in gastric cancer early diagnosis
Necula, L., Matei, L., Dragu, D., Neagu, A. I., Mambet, C., Nedeianu, S., Bleotu, C., Diaconu, C. C., & Chivu-Economescu, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2029 · Cited by 435
Yang, H., Zou, X., Yang, S., Zhang, A., Li, N., & Ma, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149989 · Cited by 139
Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer
Chen, W.-D., Zhang, X., Zhang, M.-J., Zhang, Y.-P., Shang, Z.-Q., Xin, Y.-W., & Zhang, Y. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i30.4120 · Cited by 38
Metadata
- Authors
- Feng, F., Tian, Y., Xu, G., Liu, Z., Liu, S., Zheng, G., Guo, M., Lian, X., Fan, D., & Zhang, H.
- Venue
- BMC Cancer
- Published
- 2017-11-09
- Volume
- 17
- Issue
- 1
- Pages
- 737-737
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W2767946106
- Cited by
- 373
- References
- 11
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer. https://app.cochat.ai/papers/10.1186/s12885-017-3738-y
- The paper
- Feng, F., Tian, Y., Xu, G., Liu, Z., Liu, S., Zheng, G., Guo, M., Lian, X., Fan, D., & Zhang, H. (2017). Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer. BMC Cancer. https://doi.org/10.1186/s12885-017-3738-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.